Clinical trial
Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing…
NCT00017134 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00017134 |
|---|---|
| Title | Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk |
| Official title | An Exploratory Evaluation of Fenretinide (4-HPR) as a Chemopreventive Agent for Ovarian Carcinoma |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug, Procedure |
| Interventions | fenretinide, conventional surgery |
| Enrollment | 71 |
| Start date | Sep 1, 2002 |
| Primary completion | Dec 1, 2006 |
| First posted | May 7, 2003 |
| Last update posted | Jun 10, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: